Eversept Partners, LP - Q2 2021 holdings

$1.5 Billion is the total value of Eversept Partners, LP's 87 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 70.6% .

 Value Shares↓ Weighting
SPY BuySPDR S&P 500 ETF TRput$107,015,000
+170.0%
250,000
+150.0%
7.13%
+139.3%
QQQ NewINVESCO QQQ TRput$88,607,500250,000
+100.0%
5.91%
UTHR SellUNITED THERAPEUTICS CORP DEL$79,468,762
-2.4%
442,945
-9.0%
5.30%
-13.4%
AMRN SellAMARIN CORP PLCspons adr new$73,012,283
-30.4%
16,669,471
-1.3%
4.87%
-38.3%
ARKG SellARK ETF TRgenomic rev etf$71,546,900
-0.1%
773,480
-4.1%
4.77%
-11.4%
HZNP SellHORIZON THERAPEUTICS PUB L$62,433,346
-2.5%
666,738
-4.1%
4.16%
-13.5%
AZN SellASTRAZENECA PLCsponsored adr$59,044,748
+19.7%
985,722
-0.7%
3.94%
+6.1%
CYH BuyCOMMUNITY HEALTH SYS INC NEW$59,007,496
+81.4%
3,821,729
+58.9%
3.93%
+60.9%
GSK BuyGLAXOSMITHKLINE PLCcall$55,895,334
+35.7%
1,403,700
+21.6%
3.72%
+20.3%
DHR BuyDANAHER CORPORATION$54,975,987
+37.5%
204,705
+15.3%
3.66%
+21.8%
XLRN BuyACCELERON PHARMA INC$42,044,797
+28.1%
335,045
+38.5%
2.80%
+13.6%
BIIB NewBIOGEN INCcall$40,028,812115,600
+100.0%
2.67%
TEVA SellTEVA PHARMACEUTICAL INDS LTDsponsored ads$37,663,610
-25.1%
3,804,405
-12.6%
2.51%
-33.6%
VRTX BuyVERTEX PHARMACEUTICALS INCcall$34,942,479
+171.0%
173,300
+188.8%
2.33%
+140.4%
AVTR BuyAVANTOR INC$34,609,360
+24.7%
974,637
+1.6%
2.31%
+10.6%
BMY NewBRISTOL-MYERS SQUIBB CO$31,961,877478,328
+100.0%
2.13%
ASND SellASCENDIS PHARMA A/Ssponsored adr$31,805,370
-20.9%
241,774
-22.5%
2.12%
-29.8%
QGEN BuyQIAGEN NV$31,497,073
+42.3%
651,035
+43.2%
2.10%
+26.1%
FATE BuyFATE THERAPEUTICS INC$30,059,456
+13.3%
346,347
+7.6%
2.00%
+0.5%
OCDX BuyORTHO CLINICAL DIAGNOSTICS H$29,851,620
+12.5%
1,394,284
+1.4%
1.99%
-0.3%
AMRX BuyAMNEAL PHARMACEUTICALS INC$28,798,592
-10.0%
5,624,725
+18.3%
1.92%
-20.2%
NVST SellENVISTA HOLDINGS CORPORATION$28,349,995
-5.2%
656,098
-10.5%
1.89%
-15.9%
XBI NewSPDR SER TRcall$27,080,000200,000
+100.0%
1.80%
OGN NewORGANON & CO$21,172,801699,696
+100.0%
1.41%
ARKG NewARK ETF TRcall$18,407,500199,000
+100.0%
1.23%
IONS NewIONIS PHARMACEUTICALS INC$17,631,380442,000
+100.0%
1.18%
RCM NewR1 RCM INC$17,124,800770,000
+100.0%
1.14%
HQY NewHEALTHEQUITY INC$15,894,800197,500
+100.0%
1.06%
AMN NewAMN HEALTHCARE SVCS INC$15,429,615159,101
+100.0%
1.03%
OMCL NewOMNICELL COM$14,897,53198,366
+100.0%
0.99%
MCK SellMCKESSON CORP$14,373,387
-40.1%
75,000
-39.0%
0.96%
-46.9%
XBI NewSPDR SER TRput$13,540,000100,000
+100.0%
0.90%
TARO BuyTARO PHARMACEUTICAL INDS LTD$12,538,958
+3.4%
174,249
+6.0%
0.84%
-8.2%
ARKK BuyARK ETF TRinnovation etf$11,116,300
+13.0%
85,000
+3.7%
0.74%
+0.3%
VRTX NewVERTEX PHARMACEUTICALS INC$10,988,83554,500
+100.0%
0.73%
CI BuyCIGNA CORP NEW$9,896,487
+2.3%
41,745
+4.4%
0.66%
-9.2%
MGLN  MAGELLAN HEALTH INC$9,862,740
+1.0%
104,7000.0%0.66%
-10.5%
TIP NewISHARES TRput$8,960,70070,000
+100.0%
0.60%
ALNY SellALNYLAM PHARMACEUTICALS INC$8,668,575
-24.1%
51,136
-36.8%
0.58%
-32.7%
ZGNX SellZOGENIX INC$8,568,461
-46.7%
495,860
-39.8%
0.57%
-52.7%
HUM SellHUMANA INC$8,272,025
-20.8%
18,656
-24.9%
0.55%
-29.8%
TDOC NewTELADOC HEALTH INCcall$6,651,60040,000
+100.0%
0.44%
HZNP NewHORIZON THERAPEUTICS PUB Lcall$6,554,80070,000
+100.0%
0.44%
OPCH NewOPTION CARE HEALTH INC$6,326,925289,297
+100.0%
0.42%
OM NewOUTSET MED INC$5,362,854107,300
+100.0%
0.36%
CNC SellCENTENE CORP DEL$4,959,240
-14.8%
68,000
-25.4%
0.33%
-24.4%
SRGA BuySURGALIGN HOLDINGS INC$4,906,258
-14.7%
3,882,096
+47.1%
0.33%
-24.5%
AFMD SellAFFIMED N V$4,819,007
-41.8%
566,942
-45.8%
0.32%
-48.4%
ITCI SellINTRA-CELLULAR THERAPIES INC$4,794,799
-53.0%
117,462
-60.9%
0.32%
-58.3%
GSK SellGLAXOSMITHKLINE PLCsponsored adr$4,613,279
-85.1%
112,679
-86.8%
0.31%
-86.9%
CGEM NewCULLINAN ONCOLOGY INC$4,219,910163,880
+100.0%
0.28%
DXCM SellDEXCOM INC$4,067,175
-39.6%
9,525
-49.2%
0.27%
-46.4%
ANTM SellANTHEM INC$3,868,398
-83.1%
10,132
-84.1%
0.26%
-85.0%
MRK NewMERCK & CO INCcall$3,787,39948,700
+100.0%
0.25%
KDMN SellKADMON HLDGS INC$3,463,631
-35.2%
894,995
-34.8%
0.23%
-42.5%
EXEL NewEXELIXIS INC$3,279,600180,000
+100.0%
0.22%
MRVI NewMARAVAI LIFESCIENCES HLDGS I$3,129,75075,000
+100.0%
0.21%
AUTL NewAUTOLUS THERAPEUTICS PLCspon ads$3,141,211473,074
+100.0%
0.21%
XENT BuyINTERSECT ENT INC$2,997,398
+90.4%
175,389
+132.6%
0.20%
+69.5%
IPSC NewCENTURY THERAPEUTICS INC$2,960,435100,901
+100.0%
0.20%
LQDA BuyLIQUIDIA CORPORATION$2,800,080
+108.2%
979,049
+95.8%
0.19%
+85.1%
TGTX SellTG THERAPEUTICS INC$2,705,990
-92.6%
69,760
-90.9%
0.18%
-93.5%
ISRG  INTUITIVE SURGICAL INC$2,375,430
+24.5%
2,5830.0%0.16%
+10.5%
A  AGILENT TECHNOLOGIES INC$2,255,728
+16.3%
15,2610.0%0.15%
+2.7%
HSTM NewHEALTHSTREAM INC$2,174,06777,812
+100.0%
0.14%
NVAX  NOVAVAX INCcall$2,123,100
+17.1%
10,0000.0%0.14%
+4.4%
OCUL NewOCULAR THERAPEUTIX INC$2,127,000150,000
+100.0%
0.14%
AHAC SellALPHA HEALTHCARE ACQUISTN COcl a$2,089,215
-19.3%
205,026
-14.2%
0.14%
-28.7%
ACAD BuyACADIA PHARMACEUTICALS INCcall$2,063,394
+219.9%
84,600
+238.4%
0.14%
+187.5%
TEVA NewTEVA PHARMACEUTICAL INDS LTDcall$1,909,710192,900
+100.0%
0.13%
HCA SellHCA HEALTHCARE INC$1,718,836
-89.3%
8,314
-90.3%
0.12%
-90.5%
MCRB SellSERES THERAPEUTICS INC$1,420,506
-68.0%
59,560
-72.3%
0.10%
-71.5%
GBT NewGLOBAL BLOOD THERAPEUTICS INput$1,400,80040,000
+100.0%
0.09%
IQV SellIQVIA HLDGS INC$1,384,132
+21.0%
5,712
-3.5%
0.09%
+7.0%
 TELIGENT INC NEW$1,337,389
-14.0%
2,500,2600.0%0.09%
-23.9%
IMVT SellIMMUNOVANT INC$1,164,634
-68.5%
110,183
-52.1%
0.08%
-71.9%
LXRX SellLEXICON PHARMACEUTICALS INC$1,052,437
-56.3%
229,289
-44.2%
0.07%
-61.3%
NTRA SellNATERA INC$1,057,418
-82.0%
9,314
-83.9%
0.07%
-84.1%
FREQ SellFREQUENCY THERAPEUTICS INCput$921,300
-49.9%
92,500
-52.2%
0.06%
-55.8%
FSTX NewF-STAR THERAPEUTICS INC$859,000100,000
+100.0%
0.06%
ENSG SellENSIGN GROUP INC$778,161
-71.3%
8,973
-68.9%
0.05%
-74.5%
HSKA SellHESKA CORP$783,839
-57.9%
3,412
-69.1%
0.05%
-62.9%
GOCO  GOHEALTH INC$772,358
-4.1%
68,8990.0%0.05%
-16.4%
RGEN BuyREPLIGEN CORP$736,997
+165.5%
3,692
+158.5%
0.05%
+133.3%
BIIB NewBIOGEN INCput$692,5402,000
+100.0%
0.05%
CCRN NewCROSS CTRY HEALTHCARE INC$508,67330,810
+100.0%
0.03%
GH SellGUARDANT HEALTH INC$224,660
-96.3%
1,809
-95.5%
0.02%
-96.8%
FREQ ExitFREQUENCY THERAPEUTICS INCcall$0-10,000
-100.0%
-0.01%
ExitAPTOSE BIOSCIENCES INC$0-80,000
-100.0%
-0.04%
OTIC ExitOTONOMY INCcall$0-198,400
-100.0%
-0.04%
QDEL ExitQUIDEL CORP$0-4,132
-100.0%
-0.04%
APLS ExitAPELLIS PHARMACEUTICALS INC$0-12,900
-100.0%
-0.04%
IMMP ExitIMMUTEP LTDsponsored ads$0-249,895
-100.0%
-0.06%
CABA ExitCABALETTA BIO INC$0-76,849
-100.0%
-0.06%
IFRX ExitINFLARX NV$0-268,634
-100.0%
-0.08%
RAD ExitRITE AID CORP$0-54,025
-100.0%
-0.08%
CHWY ExitCHEWY INCcl a$0-13,100
-100.0%
-0.08%
ExitCONFORMIS INC$0-1,541,978
-100.0%
-0.12%
KROS ExitKEROS THERAPEUTICS INC$0-27,631
-100.0%
-0.13%
PRTA ExitPROTHENA CORP PLC$0-68,575
-100.0%
-0.13%
XGN ExitEXAGEN INC$0-104,437
-100.0%
-0.14%
SRDX ExitSURMODICS INC$0-47,906
-100.0%
-0.20%
AMRN ExitAMARIN CORP PLCcall$0-440,800
-100.0%
-0.21%
CNC ExitCENTENE CORP DELcall$0-50,000
-100.0%
-0.24%
FPRX ExitFIVE PRIME THERAPEUTICS INC$0-93,280
-100.0%
-0.26%
LMNX ExitLUMINEX CORP DEL$0-135,471
-100.0%
-0.33%
ARKG ExitARK ETF TRput$0-56,900
-100.0%
-0.38%
NVAX ExitNOVAVAX INC$0-33,473
-100.0%
-0.46%
MNKD ExitMANNKIND CORP$0-2,165,383
-100.0%
-0.64%
ARGX ExitARGENX SEsponsored adr$0-35,886
-100.0%
-0.74%
ACAD ExitACADIA PHARMACEUTICALS INC$0-420,000
-100.0%
-0.82%
DCPH ExitDECIPHERA PHARMACEUTICALS IN$0-345,717
-100.0%
-1.16%
BHVN ExitBIOHAVEN PHARMACTL HLDG CO L$0-242,172
-100.0%
-1.24%
BDX ExitBECTON DICKINSON & CO$0-68,383
-100.0%
-1.25%
CTLT ExitCATALENT INC$0-163,114
-100.0%
-1.29%
ALXN ExitALEXION PHARMACEUTICALS INC$0-465,983
-100.0%
-5.36%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2023-11-08
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AMARIN CORP PLC21Q3 202312.5%
DANAHER CORPORATION21Q3 20238.1%
AFFIMED N V20Q3 20230.9%
ARGENX SE19Q3 20232.0%
GSK PLC18Q2 202213.1%
ASCENDIS PHARMA A/S18Q1 20227.7%
SANOFI18Q4 20227.2%
ENSIGN GROUP INC18Q1 20228.6%
CENTENE CORP DEL18Q3 20231.5%
ZOGENIX INC17Q4 202112.4%

View Eversept Partners, LP's complete holdings history.

Latest significant ownerships (13-D/G)
Eversept Partners, LP Q2 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cabaletta Bio, Inc.February 14, 2023282,8741.0%
Teligent, Inc.Sold outFebruary 16, 202100.0%
Teligent, Inc.February 14, 20204,501,7998.4%

View Eversept Partners, LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
13F-HR/A2023-11-08
13F-HR/A2023-11-08
13F-HR/A2023-11-08
13F-HR/A2023-11-08
13F-HR/A2023-11-08
13F-HR/A2023-11-08
13F-HR/A2023-11-08

View Eversept Partners, LP's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been restated
  • The reported has been amended

Export Eversept Partners, LP's holdings